Oncolytic Virus Therapy Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027

 

The global oncolytic virus therapy market is anticipated to grow at a considerable CAGR of over 15% during the forecast period (2021-2027). Oncolytic virus therapy is a promising therapeutic approach for the treatment of cancer. These oncolytic viruses destroy the cancerous cell as well as prevent the growth of tumor cells by stimulating the host anti-tumor immune responses.

The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered a suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma. The oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. 

A full report of Oncolytic Virus Therapy Market is available at: https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market

Most of the oncolytic virus therapy in clinical trials is in the preclinical phase followed by Phase-I trials. At present, two-three oncolytic drugs have been commercialized, however, around 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market include the higher incidence and prevalence rate of cancer coupled with the advent of new treatment options.

Market Coverage

·        The market number available for – 2020-2027

·        Base year- 2020

·        Forecast period- 2021-2027

·        Segment Covered-

o             By Application

o             By Product

·        Regions Covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

·        Competitive Landscape- Amgen Inc., Merck KGaA, Oncolytic Biotech, PsiOxus Therapeutics, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, and Viralytics

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market

Key questions addressed by the report

·        What is the market growth rate?

·        Which segment and region dominate the market in the base year?

·        Which segment and region will project the fastest growth in the market?

·        How has COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

·        Who is the leader in the market?

·        How are players addressing challenges to sustain growth?

·        Where is the investment opportunity?

Global Oncolytic Virus Therapy Market Report Segment

By Product

·        HSV-Based Oncolytic Viruses

·        Adenoviruses-Based Oncolytic Viruses

·        Others

By Application

·        Melanoma

·        Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/oncolytic-virus-therapy-market

Oncolytic Virus Therapy Market– Segment by Region

North America          

·        United States

·        Canada

Europe

·        Germany

·        United Kingdom

·        France

·        Spain

·        Italy

·        Rest of Europe

Asia-Pacific   

·        China

·        Japan

·        India

·        Rest of Asia-Pacific

Rest of the World

·        Middle East & Africa

·        Latin America

Company Profiles

·        Abbvie Inc.

·        Amgen Inc.

·        BenevirBiopharm, Inc.

·        Boehringer Ingelheim International GmbH

·        BioVex Inc.

·        Bristol-Myers Squibb Co.

·        Cold Genesys, Inc.

·        Creative Biolabs Inc.

·        Cynvec LLC

·        DNAtrix Inc.

·        F. Hoffmann-La Roche Ltd.

·        Genelux Corp.

·        MediGene AG

·        Merck& Co., Inc.

·        Neotropix, Inc.

Reasons to Buying From us –

1.      We cover more than 15 major industries, further segmented into more than 90 sectors.

2.      More than 120 countries are for analysis.

3.      Over 100+ paid data sources mined for investigation.

4.      Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research